Donepezil, anti-alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Arikawa, Mikihiko ^a   Kakinuma, Yoshihiko ^a   Handa, Takemi ^a   Yamasaki, Fumiyasu ^a   Sato, Takayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DONEPEZIL; GELATINASE B; MECAMYLAMINE; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVITY; HEART INFARCTION; HEART RATE; HEART RUPTURE; INCIDENCE; INFLAMMATORY CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; RISK REDUCTION; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HEART; HEART MUSCLE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ALZHEIMER DISEASE; ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; CHOLINESTERASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART; HEART RATE; HEART RUPTURE, POST-INFARCTION; HUMANS; IMMUNOHISTOCHEMISTRY; INDANS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PIPERIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960017860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020629     Document Type: Article

References (52)

1. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
2. Pavlov VA, Tracey KJ, (2006) Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 34: 1037-1040.
3. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, et al. (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124.
4. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, et al. (2005) Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 112: 164-170.
5. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, et al. (2005) Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS lett 579: 2111-2118.
6. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, et al. (2008) Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 10: 884-891.
7. Schwartz PJ, De Ferrari GM, (2009) Vagal stimulation for heart failure: background and first in-man study. Heart Rhythm 6: S76-81.
8. De Ferrari GM, Sanzo A, Schwartz PJ, (2009) Chronic vagal stimulation in patients with congestive heart failure. Conf Proc IEEE Eng Med Biol Soc pp. 2037-2039.
9. Whitehouse PJ, Struble RG, Clark AW, Price DL, (1982) Alzheimer disease: plaques, tangles, and the basal forebrain. Ann Neurol 12: 494.
10. Ryan RE, Ross SA, Drago J, Loiacono RE, (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132: 1650-1656.
11. Donnelly-Roberts DL, Xue IC, Arneric SP, Sullivan JP, (1996) In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418. Brain Res 719: 36-44.
12. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, et al. (2003) Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306: 772-777.
13. Okazaki Y, Zheng C, Li M, Sugimachi M, (2010) Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J Physiol Sci 60: 67-74.
14. Handa T, Katare RG, Kakinuma Y, Arikawa M, Ando M, et al. (2009) Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice. J Card Fail 15: 805-811.
15. Kakinuma Y, Furihata M, Akiyama T, Arikawa M, Handa T, et al. (2010) Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model. J Mol Cell Cardiol 48: 680-693.
16. Davis N, Sistino JJ, (2002) Review of ventricular rupture: key concepts and diagnostic tools for success. Perfusion 17: 63-67.
17. Figueras J, Cortadellas J, Evangelista A, Soler-Soler J, (1997) Medical management of selected patients with left ventricular free wall rupture during acute myocardial infarction. J Am Coll Cardiol 29: 512-518.
18. Purcaro A, Costantini C, Ciampani N, Mazzanti M, Silenzi C, et al. (1997) Diagnostic criteria and management of subacute ventricular free wall rupture complicating acute myocardial infarction. Am J Cardiol 80: 397-405.
19. McMullan MH, Maples MD, Kilgore TL Jr, Hindman SH, (2001) Surgical experience with left ventricular free wall rupture. Ann Thorac Surg 71: 1894-1898.
20. Leva C, Bruno PG, Gallorini C, Lazzarini I, Musazzi G, et al. (2006) Complete myocardial revascularization and sutureless technique for left ventricular free wall rupture: clinical and echocardiographic results. Interactive Cardiovasc Thorac Surg 5: 408-412.
21. Sakaguchi G, Komiya T, Tamura N, Kobayashi T, (2008) Surgical treatment for postinfarction left ventricular free wall rupture. Ann Thorac Surg; 85: 1344-1346.
22. Batts KP, Ackermann DM, Edwards WD, (1990) Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases. Hum Pathol 21: 530-535.
23. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, et al. (2007) Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 43: 535-544.
24. Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, et al. (2010) Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol 143: 20-28.
25. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, et al. (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142.
26. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, et al. (1999) Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99: 3063-3070.
27. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, et al. (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62.
28. Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, et al. (2002) Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105: 753-758.
29. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, et al. (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol 285: H1229-1235.
30. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, et al. (2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115: 599-609.
31. Pfeffer JM, Pfeffer MA, Fletcher P, Braunwald E, (1979) Alterations of cardiac performance in rats with established spontaneous hypertension. Am J Cardiol 44: 994-998.
32. Pfeffer JM, Pfeffer MA, Braunwald E, (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57: 84-95.
33. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
34. Zhang Y, Kakinuma Y, Ando M, Katare RG, Yamasaki F, et al. (2006) Acetylcholine inhibits the hypoxia-induced reduction of connexin43 protein in rat cardiomyocytes. J Pharmacol Sci 101: 214-222.
35. Katare RG, Ando M, Kakinuma Y, Arikawa M, Handa T, et al. (2009) Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect. J Thorac Cardiovasc Surg 137: 223-231.
36. Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, et al. (2004) Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 164: 665-677.
37. Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ, (2005) Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 65: 469-477.
38. Yang Y, Ma Y, Han W, Li J, Xiang Y, et al. (2008) Age-related differences in postinfarct left ventricular rupture and remodeling. Am J Physiol 294: H1815-1822.
39. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ, (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89: 201-210.
40. Lindsey ML, (2004) MMP induction and inhibition in myocardial infarction. Heart Fail Rev 9: 7-19.
41. Lambert JM, Lopez EF, Lindsey ML, (2008) Macrophage roles following myocardial infarction. Int J Cardiol 130: 147-158.
42. Nagaoka I, Hirota S, (2000) Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs. Inflamm Res 49: 55-62.
43. Arikawa M, Katare RG, Kakinuma Y, Handa T, Ando M, et al. (2007) Progression of ventricular dysfunction after myocardial infarction is prevented by anti-Alzheimer's disease drug, donepezil. Circulation 116: II_291.
44. Li M, Zheng C, Kawada T, Inagaki M, Sato T, et al. (2009) Donepezil markedly suppresses ventricular dysfunction and improves neurohumoral states on top of losartan in rats with extensive myocardial infarction. Circulation 120: S1178.
45. Fang L, Gao XM, Samuel CS, Su Y, Lim YL, et al. (2008) Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction. Clin Sci (Lond) 115: 99-106.
46. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, et al. (2001) Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103: 2303-2309.
47. Spinale FG, Coker ML, Krombach SR, Mukherjee R, Hallak H, et al. (1999) Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 85: 364-376.
48. Shepherd G, Klein-Schwartz W, Edwards R, (1999) Donepezil overdose: a tenfold dosing error. Ann Pharmacother 33: 812-815.
49. Sato K, Urbano R, Yu C, Yamasaki F, Sato T, et al. (2010) The effect of donepezil treatment on cardiovascular mortality. Clin Pharmacol Ther 88: 335-338.
50. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, et al. (2008) Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. J Neurosci Res 86: 3575-3583.
51. Akasofu S, Kimura M, Kosasa T, Sawada K, Ogura H, (2008) Study of neuroprotection of donepezil, a therapy for Alzheimer's disease. Chem Biol Interact 175: 222-226.
52. Akaike A, Takada-Takatori Y, Kume T, Izumi Y, (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 40: 211-216.